Chemoinformaics analysis of Styrene Oxyresveratrol
| Molecular Weight | 304.342 | nRot | 9 |
| Heavy Atom Molecular Weight | 284.182 | nRig | 10 |
| Exact Molecular Weight | 304.131 | nRing | 1 |
| Solubility: LogS | -2.475 | nHRing | 0 |
| Solubility: LogP | 1.315 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 45.7359 |
| nHD | 1 | BPOL | 24.4041 |
| QED | 0.43 |
| Synth | 3.379 |
| Natural Product Likeliness | 1.506 |
| NR-PPAR-gamma | 0.784 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.285 |
| CACO-2 | -4.599 |
| MDCK | 0.0000185 |
| BBB | 0.469 |
| PPB | 0.57752 |
| VDSS | 0.754 |
| FU | 0.575176 |
| CYP1A2-inh | 0.227 |
| CYP1A2-sub | 0.095 |
| CYP2c19-inh | 0.561 |
| CYP2c19-sub | 0.078 |
| CYP2c9-inh | 0.184 |
| CYP2c9-sub | 0.823 |
| CYP2d6-inh | 0.14 |
| CYP2d6-sub | 0.294 |
| CYP3a4-inh | 0.294 |
| CYP3a4-sub | 0.262 |
| CL | 12.24 |
| T12 | 0.926 |
| hERG | 0.027 |
| Ames | 0.367 |
| ROA | 0.048 |
| SkinSen | 0.962 |
| Carcinogencity | 0.825 |
| EI | 0.975 |
| Respiratory | 0.781 |
| NR-Aromatase | 0.267 |
| Antiviral | Yes |
| Prediction | 0.739511 |